Searched for
NEW ANTIBIOTICS
For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%- Shigella outbreak in Kerala: 10 new cases reported taking tally to 226; here's everything you need to know about the infection
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal Manchanda
- Drugmakers yet to see gains from government's minimum import price policyGovernment's Minimum Import Price (MIP) initiative to boost domestic drug makers faces a slow start. Despite setting price thresholds for k...23 Jun, 2026, 12.28 AM IST
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...22 Jun, 2026, 12.25 PM IST
- Palestinian Embassy calls for urgent medical aid: "If not India and Indian people, then who?"Palestine's Embassy in India has issued a dire plea for immediate medical aid, warning of a healthcare sector collapse due to ongoing confl...20 Jun, 2026, 09.06 AM IST
- A new nanotech breakthrough could help heal dangerous wounds antibiotics can’t treatScientists are using nanomaterials to heal stubborn wounds that resist antibiotic treatment through a new era of smart wound care. These li...18 Jun, 2026, 09.38 PM IST
- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...10 Jun, 2026, 09.05 AM IST
- India’s rising export champion faces a critical credibility testIndia's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...06 Jun, 2026, 02.43 PM IST
- Banned substance in shrimp: Vet shops under close watchIndia's top drug regulator is cracking down on veterinary shops. This action follows a significant rejection of shrimp exports to major mar...06 Jun, 2026, 12.26 AM IST
- CG Power's growth momentum strong, but valuation comfort missing: Sandip SabharwalCG Power expands its switchgear production, signaling strong demand in the power equipment sector. However, market expert Sandip Sabharwal ...05 Jun, 2026, 12.59 PM IST
- The gut-brain bombshell: How bacteria in babies may hold the key to preventing Autism, ADHDNew research reveals a significant link between a baby's early gut bacteria and future brain health, potentially influencing the risk of co...04 Jun, 2026, 12.20 AM IST
- FirstClub raises $55 million from Peak XV, Sofina; valuation doubles to $255 millionQuality-focused grocery delivery startup FirstClub has secured $55 million in a Series B funding round led by Peak XV Partners and Sofina, ...04 Jun, 2026, 12.00 AM IST
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...02 Jun, 2026, 11.10 AM IST
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...02 Jun, 2026, 05.48 AM IST
- Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...02 Jun, 2026, 12.05 AM IST
- If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...02 Jun, 2026, 12.01 AM IST
- Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...01 Jun, 2026, 04.49 PM IST
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...01 Jun, 2026, 07.44 AM IST
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...30 May, 2026, 11.17 PM IST
Load More
